United States · FDA National Drug Code directory
Trintellix
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-730_186fcd68-438e-427f-ae19-8042c15baa78
- Product NDC
- 64764-730
- Form
- TABLET, FILM COATED
- Composition / generic term
- vortioxetine
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20131002
- Source listing expiry
- 20261231
Source-listed ingredients
- VORTIOXETINE HYDROBROMIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (64764-730-07) / 7 TABLET, FILM COATED in 1 BOTTLE · 64764-730-07
- 30 TABLET, FILM COATED in 1 BOTTLE (64764-730-09) · 64764-730-09
- 30 TABLET, FILM COATED in 1 BOTTLE (64764-730-30) · 64764-730-30
- 500 TABLET, FILM COATED in 1 BOTTLE (64764-730-77) · 64764-730-77
- 90 TABLET, FILM COATED in 1 BOTTLE (64764-730-90) · 64764-730-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →